Obstructive Sleep Apnea Clinical Trial
Official title:
Determination of Upper Airway Collapsibility During Routine CPAP Titration
The investigators hypothesis is that upper airway collapsibility (Pcrit) in patients with obstructive sleep apnea (OSA) can be measured using equipment found in the clinical sleep laboratory and these Pcrit measurements obtained using clinical sleep laboratory equipment is comparable to those obtained using research equipment. OSA is a common disease characterized by repetitive collapse of the upper airway during sleep, leading to hypoxemia and arousals, and which has important neurocognitive and cardiovascular consequences. The single most important factor in the development of OSA is upper airway collapsibility: those with a more collapsible upper airway tend to have OSA while those with a stiffer upper airway do not. The gold standard treatment for OSA is continuous positive airway pressure (CPAP), which acts by stenting open the collapsible airway. Upper airway collapsibility can be measured during sleep by changing the CPAP level and assessing the change in inspiratory flow through the upper airway. Although technically feasible, these measurements are typically only undertaken in research laboratories with specialized equipment. The purpose of this study is to measure upper airway collapsibility using clinically available (i.e. equipment found in a clinical sleep laboratory) equipment only. If successful, upper airway collapsibility could be routinely measured in clinical practice, which could help inform treatment decisions and help individualize therapy for OSA.
OSA is defined by total or partial intermittent collapse of the upper airway, resulting in
nocturnal hypoxemia and arousals from sleep. OSA is incredible common and has important
cardiovascular (e.g. hypertension, coronary artery disease, stroke, atrial fibrillation) and
neurocognitive consequences (e.g. depression, motor vehicle accidents). Thus, OSA results in
significant morbidity and mortality and a substantial economic burden. The best studied
treatment of OSA is continuous positive airway pressure (CPAP), which effectively stents the
upper airway open, however, many patients are not able to tolerate it. Other treatments are
available, such as oral appliances or upper airway surgery, however these are much more
variable in their effectiveness.
Although other factors are important, the most important factor in OSA pathogenesis is upper
airway collapsibility. The upper airway collapsibility can be determined during sleep when
patients with OSA are on CPAP. The CPAP level is decreased until flow limitation and finally
collapse is achieved. The pressure at which the airway collapses is called the pharyngeal
critical closing pressure, or Pcrit. When measured in research laboratories, the Pcrit
correlates with OSA severity. Subjects with a high Pcrit (e.g. 5cm of water pressure)
typically have severe OSA, while those with a lower Pcrit (e.g. 2cm of water pressure) have
mild OSA, and those with a negative Pcrit (e.g. -4cm of water, the airway must be sucked
closed to collapse) typically have no disease. The Pcrit may also have important implications
for treatment. For example, patients with OSA and a very high Pcrit may require CPAP,
however, those with a lower or slightly negative Pcrit might be successfully treated by an
oral appliance. Thus, knowledge of the Pcrit might be useful in clinical practice, but it is
rarely measured outside of the research lab.
To measure Pcrit, patients sleep with a mask over their nose or nose and mouth, and CPAP is
applied using a custom made machine that can rapidly change mask pressures. The idea is that
rapid changes in airway pressure produce a clear step change in airflow that will be observed
quickly. In contrast, during clinical titrations, the CPAP machines change pressure much more
slowly to help promote patient comfort. The goal of this research is to determine whether
these slower pressure changes could still be used to gather useful information about upper
airway collapsibility.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05857384 -
Bioavailability, Bioequivalence and Tolerability of IHL-42X Compared to the Reference Drugs
|
Phase 1 | |
Recruiting |
NCT04547543 -
Follow-up of Apneic Patients by Visio-consultation
|
N/A | |
Recruiting |
NCT05371509 -
Novel Myofunctional Water Bottle to Reduce OSA and Snoring Study
|
N/A | |
Completed |
NCT02515357 -
Mediterranean Diet/Lifestyle Intervention in Obstructive Sleep Apnea
|
N/A | |
Completed |
NCT05582070 -
Effect on Sleep of Surgical Treatment of Severe Nasal Obstruction
|
N/A | |
Active, not recruiting |
NCT03189173 -
Combined Upper-airway and Breathing Control Therapies for Obstructive Sleep Apnea
|
Phase 2 | |
Completed |
NCT04084899 -
The Effect of CPAP on Lung Hyperinflation in Patients With OSA
|
||
Completed |
NCT03032029 -
Registry on the Treatment of Central and Complex Sleep-Disordered Breathing With Adaptive Servo-Ventilation
|
||
Recruiting |
NCT04028011 -
Clinical Evaluation of a Wearable Technology for the Diagnosis of Sleep Apnoea
|
||
Recruiting |
NCT06047353 -
Community Health Advocates for Motivating PAP Use in Our Neighborhoods.
|
N/A | |
Completed |
NCT05253963 -
Acute Effect of CPAP on Weight in Patients With Obstructive Sleep Apnea
|
N/A | |
Recruiting |
NCT06029959 -
Stroke and CPAP Outcome Study 3
|
N/A | |
Recruiting |
NCT06150352 -
Sleep Apnea, Neurocognitive Decline and Brain Imaging in Patients With Subjective or Mild Cognitive Impairment
|
||
Completed |
NCT03589417 -
Postural Stability, Balance and Fall Risk in Patients With Obstructive Sleep Apnea
|
||
Recruiting |
NCT04335994 -
ENhancing Outcomes in Cognitive Impairment Through Use of Home Sleep ApNea Testing
|
N/A | |
Withdrawn |
NCT04063436 -
Evaluation of a New Nasal Pillows Mask for the Treatment of Obstructive Sleep Apnea
|
N/A | |
Recruiting |
NCT05385302 -
Sociological Determinants of Positive Airway Pressure Adherence in OSA Patients
|
||
Recruiting |
NCT04572269 -
Metabolomics of Obstructive Sleep Apnea
|
||
Not yet recruiting |
NCT06467682 -
12-week Tele-exercise Program in Patients With OSA
|
N/A | |
Withdrawn |
NCT04011358 -
Retinal Vein Occlusion and Obstructive Sleep Apnea: A Case Control Study
|
N/A |